Fig. 1From: The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trialsFlowchart of study selection for inclusion of trials in the meta-analysisBack to article page